Patent · US Active

Zn3(BDC)3[Cu(SalPycy)] and Zn3(CDC)3[Cu(SalPycy)]—enantiopure mixed metal-organic frameworks for selective separations and enantioselective recognition

US9296773B2 · kind B2 · utility

0Cited by

1References

20Claims

0Family size

Assignee

The Board of Regents of the University of Texas System · US

Inventors

Banglin Chen · San Antonio, US
Shengchang XIANG · Fujian, CN

Key dates

Filing date	Jan 17, 2013
Grant date	Mar 29, 2016
Priority date	—
Expiry date	Feb 5, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/151
WIPO fieldChemical engineering
WIPO sectorChemistry

Abstract

Disclosed herein are mixed metal-organic frameworks, Zn3(BDC)3[Cu(SalPycy)] and Zn3(CDC)3[Cu(SalPycy)], wherein BDC is 1,4-benzenedicarboxylate, CDC is 1,4-cyclohexanedicarboxylate, and SalPyCy is a ligand of the formula:These are useful for applications such as selective gas storage, selective molecular separations, and selective detection of molecules, including enantioselective applications thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.